ACRS Competitors & Alternatives
Compare Aclaris Therapeutics Inc with similar stocks in the same industry
Biotechnology
ACRS
Main Stock$4.24
Tradestie Score
37
Market Cap
$202.58M
Revenue Growth
-0.6%
Analyst Upside
+144.4%
Top Competitors
219 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
TBPH
Theravance Biopharma, Inc.
|
$17.03
|
$726.21M | 16.4 | 51 | Compare |
|
NRIX
Nurix Therapeutics, Inc. Common stock
|
$16.19
|
$718.62M | 6.6 | 46 | Compare |
|
ANL
ANL
|
$10.24
|
$718.04M | - | 51 | Compare |
|
TYRA
Tyra Biosciences, Inc. Common Stock
|
$21.04
|
$715.25M | - | 47 | Compare |
|
DAWN
Day One Biopharmaceuticals, Inc. Common Stock
|
$21.53
|
$704.73M | - | 51 | Compare |
|
PVLA
Palvella Therapeutics, Inc. Common Stock
|
$167.19
|
$699.30M | - | 33 | Compare |
|
GYRE
Gyre Therapeutics, Inc. Common Stock
|
$4.34
|
$688.47M | - | 59 | Compare |
|
TERN
Terns Pharmaceuticals, Inc. Common Stock
|
$52.95
|
$683.46M | - | 49 | Compare |
|
MGTX
MeiraGTx Holdings plc Ordinary Shares
|
$9.67
|
$665.30M | 10.9 | 59 | Compare |
|
ERAS
Erasca, Inc. Common Stock
|
$16.43
|
$626.91M | - | 53 | Compare |
More ACRS Analysis
Data updated: Nov 11, 2026 | Industry: Biotechnology (SIC 2834)
219 stocks in this industry